Construction of data for implementation of comprehensive cancer genome profiling using genome-guided system
Not Applicable
Recruiting
- Conditions
- Solid cancer
- Registration Number
- JPRN-UMIN000052151
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Cases judged by the principal investigator to be inappropriate for participation in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients for whom genome-guided treatment could be proposed among patients who underwent cancer gene panel testing at St. Marianna University Hospital and were analysed using the MH Guide for annotation based on measured data.
- Secondary Outcome Measures
Name Time Method druggable genomic alterations *Definition in the St. Marianna University Hospital Expert Panel: genomic alterations with evidence level C1 or higher or evidence level D2 and promising investigational drugs in the Guidance for cancer treatment based on gene panel testing using next-generation sequencers. *Definition in the MH Guide: genomic alterations with a Biomarker score of 4 or more. Time spent on annotation.